Cite
APA Citation
Smith, P. J., Critchley, L., Storey, D., Gregg, B., Stenson, J., Kneebone, A., Rimmer, T., Burke, S., Hussain, S., Yi Teoh, W., Vazeille, S., Serna, S., Steel, A., Derbyshire, E., Collins, P., Dibb, M., Flanagan, P., Probert, C., Verma, A. M., & Subramanian, S. (2022). efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. Journal of Crohn's and colitis, 16, 1436–1446. http://access.bl.uk/ark:/81055/vdc_100163927096.0x00001c